Have You Been Denied Evrysdi (formerly Risdiplam), Spinraza or Zolgensma to treat Spinal Muscular Atrophy (SMA)?
If the answer is yes, we can help. Call now or fill out the Free Consultation form on this page.
Spinal Muscular Atrophy is a genetic degenerative disease that impacts the motor nerve cells in the spinal cord. People who have this disease can lose their ability to breathe, eat and walk. There are three FDA approved medications to treat SMA including Spinraza, Zolgensma, and now Evrysidi (formerly Risdiplam).
But some insurance providers deny these treatments because they are expensive. Has someone in your family been denied Evrysidi, Spinraza or Zolgensma by one of the following insurance companies:
- Anthem Blue Cross,
- Blue Shield,
- Health Net,
- Aetna, or
- another insurance company?
The Law Offices of Scott Glovsky can help you.
Los Angeles and California health insurance denial attorney Scott Glovsky helps members seek justice for medically necessary denials. Please call our office or fill out the Free Consultation form on this page.